Nature (almost) always prevails – challenging the status quo of artificial cycle frozen embryo transfers
Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the implementation of the ‘freeze-all’ strategy. The choice between artificial or natural cycles for FET preparation has been a subject of d...
Saved in:
Published in | Reproductive biomedicine online Vol. 47; no. 6; p. 103352 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the implementation of the ‘freeze-all’ strategy. The choice between artificial or natural cycles for FET preparation has been a subject of debate, considering factors such as endometrial receptivity, flexibility of scheduling and pregnancy outcomes. While artificial cycle protocols offer convenience and flexibility, studies have suggested potential drawbacks, including higher miscarriage rates and a greater risk of hypertensive disorders during pregnancy. In contrast, natural cycle protocols involve a frequently demanding monitoring of both endometrial proliferation and follicular growth, which may lead to increased clinic visits and scheduling issues. Multiple strategies have been proposed to enhance the usage of natural cycle FET, including addressing anovulation through minimal stimulation, reducing cycle monitoring and exploring novel FET approaches. These novel approaches, such as widening the window for human chorionic gonadotrophin administration and the natural proliferative phase protocol, offer promising outcomes and increased convenience for patients. However, further research is needed to establish the optimal timing and effectiveness of these strategies. Overall, enhancing the practicality of natural cycle FETs is crucial for expanding their utilization during ART. |
---|---|
AbstractList | Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the implementation of the 'freeze-all' strategy. The choice between artificial or natural cycles for FET preparation has been a subject of debate, considering factors such as endometrial receptivity, flexibility of scheduling and pregnancy outcomes. While artificial cycle protocols offer convenience and flexibility, studies have suggested potential drawbacks, including higher miscarriage rates and a greater risk of hypertensive disorders during pregnancy. In contrast, natural cycle protocols involve a frequently demanding monitoring of both endometrial proliferation and follicular growth, which may lead to increased clinic visits and scheduling issues. Multiple strategies have been proposed to enhance the usage of natural cycle FET, including addressing anovulation through minimal stimulation, reducing cycle monitoring and exploring novel FET approaches. These novel approaches, such as widening the window for human chorionic gonadotrophin administration and the natural proliferative phase protocol, offer promising outcomes and increased convenience for patients. However, further research is needed to establish the optimal timing and effectiveness of these strategies. Overall, enhancing the practicality of natural cycle FETs is crucial for expanding their utilization during ART. Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the implementation of the 'freeze-all' strategy. The choice between artificial or natural cycles for FET preparation has been a subject of debate, considering factors such as endometrial receptivity, flexibility of scheduling and pregnancy outcomes. While artificial cycle protocols offer convenience and flexibility, studies have suggested potential drawbacks, including higher miscarriage rates and a greater risk of hypertensive disorders during pregnancy. In contrast, natural cycle protocols involve a frequently demanding monitoring of both endometrial proliferation and follicular growth, which may lead to increased clinic visits and scheduling issues. Multiple strategies have been proposed to enhance the usage of natural cycle FET, including addressing anovulation through minimal stimulation, reducing cycle monitoring and exploring novel FET approaches. These novel approaches, such as widening the window for human chorionic gonadotrophin administration and the natural proliferative phase protocol, offer promising outcomes and increased convenience for patients. However, further research is needed to establish the optimal timing and effectiveness of these strategies. Overall, enhancing the practicality of natural cycle FETs is crucial for expanding their utilization during ART.Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the implementation of the 'freeze-all' strategy. The choice between artificial or natural cycles for FET preparation has been a subject of debate, considering factors such as endometrial receptivity, flexibility of scheduling and pregnancy outcomes. While artificial cycle protocols offer convenience and flexibility, studies have suggested potential drawbacks, including higher miscarriage rates and a greater risk of hypertensive disorders during pregnancy. In contrast, natural cycle protocols involve a frequently demanding monitoring of both endometrial proliferation and follicular growth, which may lead to increased clinic visits and scheduling issues. Multiple strategies have been proposed to enhance the usage of natural cycle FET, including addressing anovulation through minimal stimulation, reducing cycle monitoring and exploring novel FET approaches. These novel approaches, such as widening the window for human chorionic gonadotrophin administration and the natural proliferative phase protocol, offer promising outcomes and increased convenience for patients. However, further research is needed to establish the optimal timing and effectiveness of these strategies. Overall, enhancing the practicality of natural cycle FETs is crucial for expanding their utilization during ART. |
ArticleNumber | 103352 |
Author | Reis-Soares, Sérgio Santos-Ribeiro, Samuel Godinho, Catarina M |
Author_xml | – sequence: 1 givenname: Samuel orcidid: 0000-0003-2476-7858 surname: Santos-Ribeiro fullname: Santos-Ribeiro, Samuel email: samuel.ribeiro@ivirma.com organization: IVIRMA Global Research Alliance, IVIRMA Lisboa, Lisbon, Portugal – sequence: 2 givenname: Catarina M surname: Godinho fullname: Godinho, Catarina M organization: IVIRMA Global Research Alliance, IVIRMA Lisboa, Lisbon, Portugal – sequence: 3 givenname: Sérgio surname: Reis-Soares fullname: Reis-Soares, Sérgio organization: IVIRMA Global Research Alliance, IVIRMA Lisboa, Lisbon, Portugal |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37804605$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkbtuFDEYRi0URC7wAhTIZSh28WVm7CAaFHGTImigtjz278SLx97YnqCh4h14Q54ErzakSBEqW9Y5Ls53jA5iioDQc0rWlNDh1WadxymtGWG8PXDes0foiHaCrYbujB7c3SU_RMelbAihkkj-BB1yIUk3kP4IbT7rOmfApzpMqdSXWIcfeil4m-FG-1Dwn1-_sbnSIUC89PES1yvApTap4Os54eSwztU7b7wO2CwmAHY5_YSIYRrzknDNOhYHuTxFj50OBZ7dnifo2_t3X88_ri6-fPh0_vZiZbqe1hUFZwcrBYiRUaMdsZoby8XZyPhIiRPWkUFaw0Rnekq1YSNllIm-6yUfgPITdLr_d5vT9QylqskXAyHoCGkuiknRsV62Ag19cYvO4wRWbbOfdF7Uvz4NYHvA5FRKBneHUKJ2I6iN2o2gdiOo_QhNkvck41sxn2Jr4cPD6pu9Ci3QjYesivEQDVifwVRlk39Yf31PN8FHb3T4Dsv_5L_e8bcu |
CitedBy_id | crossref_primary_10_1016_j_rbmo_2023_103775 crossref_primary_10_1016_j_fertnstert_2024_09_041 crossref_primary_10_1007_s00129_025_05350_1 crossref_primary_10_1007_s41974_024_00351_9 crossref_primary_10_1016_j_rbmo_2024_104350 |
Cites_doi | 10.1016/j.fertnstert.2019.12.024 10.1016/j.fertnstert.2021.07.455 10.1161/HYPERTENSIONAHA.118.12043 10.1186/s12958-023-01096-4 10.3389/fendo.2021.688237 10.1016/j.fertnstert.2019.04.014 10.1007/s10815-020-01994-1 10.1093/humrep/dead093.026 10.1016/j.rbmo.2019.04.003 |
ContentType | Journal Article |
Copyright | 2023 Reproductive Healthcare Ltd. Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2023 Reproductive Healthcare Ltd. – notice: Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.rbmo.2023.103352 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1472-6491 |
ExternalDocumentID | 37804605 10_1016_j_rbmo_2023_103352 S1472648323004522 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 29P 36B 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABDBF ABFNM ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACUHS ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN B0M BKOJK BLXMC BNPGV DU5 EAP EBS EFJIC EFKBS EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA HVGLF HZ~ KOM M41 ML~ MO0 O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- ROL SDF SEL SES SJN SPCBC SSH SSZ SV3 T5K TUS XH2 Z5R ~8M ~G- 0SF AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW EFLBG LCYCR NCXOZ AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c451t-1efd6d87e7b21caf0da3cd379b23b10f7df068dc274c511ac2b12127545836e13 |
IEDL.DBID | .~1 |
ISSN | 1472-6483 1472-6491 |
IngestDate | Fri Jul 11 03:53:45 EDT 2025 Mon Jul 21 05:43:37 EDT 2025 Tue Jul 01 01:54:04 EDT 2025 Thu Apr 24 23:02:07 EDT 2025 Sat Mar 02 16:00:12 EST 2024 Tue Aug 26 20:24:03 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Artificial cycle Frozen embryo transfer Natural proliferative phase Assisted reproductive technologies Natural cycle |
Language | English |
License | Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c451t-1efd6d87e7b21caf0da3cd379b23b10f7df068dc274c511ac2b12127545836e13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2476-7858 |
OpenAccessLink | http://www.rbmojournal.com/article/S1472648323004522/pdf |
PMID | 37804605 |
PQID | 2874258804 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2874258804 pubmed_primary_37804605 crossref_primary_10_1016_j_rbmo_2023_103352 crossref_citationtrail_10_1016_j_rbmo_2023_103352 elsevier_sciencedirect_doi_10_1016_j_rbmo_2023_103352 elsevier_clinicalkey_doi_10_1016_j_rbmo_2023_103352 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2023 2023-12-00 20231201 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: December 2023 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Reproductive biomedicine online |
PublicationTitleAlternate | Reprod Biomed Online |
PublicationYear | 2023 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Dozortsev, Pellicer, Diamond (bib0004) 2020; 113 Johal, Bavan, Zhang, Gardner, Lathi, Milki (bib0007) 2021; 38 Zhang, Liu, Wang, Mao, Chen, Fan, Xiao, Kuang (bib0010) 2019; 112 von Versen-Hoynck, Schaub, Chi, Chiu, Liu, Lingis, Stan Williams, Rhoton-Vlasak, Nichols, Fleischmann (bib0009) 2019; 73 Godinho, Mascarós Martinez, Neves, Semenova, Nunes, Reis Soares, Santos-Ribeiro (bib0005) 2023; 38 Godinho, Soares, Santos-Ribeiro (bib0006) 2021; 116 Bartels, Ditrio, Grow, O'Sullivan, Benadiva, Engmann, Nulsen (bib0002) 2019; 39 Coughlan, Ata, Gallego, Lawrenz, Melado, Samir, Fatemi (bib0003) 2023; 21 Mumusoglu, Polat, Ozbek, Bozdag, Papanikolaou, Esteves, Humaidan, Yarali (bib0008) 2021; 12 Alonso, Kohls, Caballero, Santos-Ribeiro, Soares, García Velasco (bib0001) 2023; 38 Godinho (10.1016/j.rbmo.2023.103352_bib0005) 2023; 38 Johal (10.1016/j.rbmo.2023.103352_bib0007) 2021; 38 Coughlan (10.1016/j.rbmo.2023.103352_bib0003) 2023; 21 Godinho (10.1016/j.rbmo.2023.103352_bib0006) 2021; 116 Alonso (10.1016/j.rbmo.2023.103352_bib0001) 2023; 38 Mumusoglu (10.1016/j.rbmo.2023.103352_bib0008) 2021; 12 Zhang (10.1016/j.rbmo.2023.103352_bib0010) 2019; 112 von Versen-Hoynck (10.1016/j.rbmo.2023.103352_bib0009) 2019; 73 Bartels (10.1016/j.rbmo.2023.103352_bib0002) 2019; 39 Dozortsev (10.1016/j.rbmo.2023.103352_bib0004) 2020; 113 |
References_xml | – volume: 73 start-page: 640 year: 2019 end-page: 649 ident: bib0009 article-title: Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum publication-title: Hypertension – volume: 39 start-page: 241 year: 2019 end-page: 248 ident: bib0002 article-title: The window is wide: flexible timing for vitrified-warmed embryo transfer in natural cycles publication-title: Reprod. Biomed. Online – volume: 38 year: 2023 ident: bib0005 article-title: P-653 Natural proliferative phase frozen embryo transfers: a novel, safe and efficient transfer strategy publication-title: Hum. Reprod. – volume: 112 start-page: 371 year: 2019 end-page: 377 ident: bib0010 article-title: Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome publication-title: Fertil. Steril. – volume: 21 start-page: 47 year: 2023 ident: bib0003 article-title: Interindividual variation of progesterone elevation post LH rise: implications for natural cycle frozen embryo transfers in the individualized medicine era publication-title: Reprod. Biol. Endocrinol. – volume: 38 start-page: 219 year: 2021 end-page: 225 ident: bib0007 article-title: The impact of timing modified natural cycle frozen embryo transfer based on spontaneous luteinizing hormone surge publication-title: J. Assist. Reprod. Genet. – volume: 12 year: 2021 ident: bib0008 article-title: Preparation of the Endometrium for Frozen Embryo Transfer: A Systematic Review publication-title: Front. Endocrinol. (Lausanne) – volume: 38 year: 2023 ident: bib0001 article-title: O-026 A new mNC protocol that allows a 7-day window for FET planning publication-title: Hum. Reprod. – volume: 113 start-page: 923 year: 2020 end-page: 924 ident: bib0004 article-title: Progesterone is a physiological trigger of ovulatory gonadotropins publication-title: Fertil. Steril. – volume: 116 start-page: e165 year: 2021 ident: bib0006 article-title: Natural proliferative phase frozen embryo transfers (NPP-FET): a new approach that facilitates scheduling without hindering pregnancy outcomes publication-title: Fertil. Steril. – volume: 113 start-page: 923 year: 2020 ident: 10.1016/j.rbmo.2023.103352_bib0004 article-title: Progesterone is a physiological trigger of ovulatory gonadotropins publication-title: Fertil. Steril. doi: 10.1016/j.fertnstert.2019.12.024 – volume: 116 start-page: e165 year: 2021 ident: 10.1016/j.rbmo.2023.103352_bib0006 article-title: Natural proliferative phase frozen embryo transfers (NPP-FET): a new approach that facilitates scheduling without hindering pregnancy outcomes publication-title: Fertil. Steril. doi: 10.1016/j.fertnstert.2021.07.455 – volume: 73 start-page: 640 year: 2019 ident: 10.1016/j.rbmo.2023.103352_bib0009 article-title: Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.118.12043 – volume: 21 start-page: 47 year: 2023 ident: 10.1016/j.rbmo.2023.103352_bib0003 article-title: Interindividual variation of progesterone elevation post LH rise: implications for natural cycle frozen embryo transfers in the individualized medicine era publication-title: Reprod. Biol. Endocrinol. doi: 10.1186/s12958-023-01096-4 – volume: 12 year: 2021 ident: 10.1016/j.rbmo.2023.103352_bib0008 article-title: Preparation of the Endometrium for Frozen Embryo Transfer: A Systematic Review publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2021.688237 – volume: 38 year: 2023 ident: 10.1016/j.rbmo.2023.103352_bib0005 article-title: P-653 Natural proliferative phase frozen embryo transfers: a novel, safe and efficient transfer strategy publication-title: Hum. Reprod. – volume: 112 start-page: 371 year: 2019 ident: 10.1016/j.rbmo.2023.103352_bib0010 article-title: Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome publication-title: Fertil. Steril. doi: 10.1016/j.fertnstert.2019.04.014 – volume: 38 start-page: 219 year: 2021 ident: 10.1016/j.rbmo.2023.103352_bib0007 article-title: The impact of timing modified natural cycle frozen embryo transfer based on spontaneous luteinizing hormone surge publication-title: J. Assist. Reprod. Genet. doi: 10.1007/s10815-020-01994-1 – volume: 38 year: 2023 ident: 10.1016/j.rbmo.2023.103352_bib0001 article-title: O-026 A new mNC protocol that allows a 7-day window for FET planning publication-title: Hum. Reprod. doi: 10.1093/humrep/dead093.026 – volume: 39 start-page: 241 year: 2019 ident: 10.1016/j.rbmo.2023.103352_bib0002 article-title: The window is wide: flexible timing for vitrified-warmed embryo transfer in natural cycles publication-title: Reprod. Biomed. Online doi: 10.1016/j.rbmo.2019.04.003 |
SSID | ssj0018083 |
Score | 2.415666 |
Snippet | Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 103352 |
SubjectTerms | Artificial cycle Assisted reproductive technologies Cryopreservation - methods Embryo Transfer - methods Female Frozen embryo transfer Humans Natural cycle Natural proliferative phase Ovulation Induction - methods Pregnancy Pregnancy Outcome Pregnancy Rate Reproductive Techniques, Assisted Retrospective Studies |
Title | Nature (almost) always prevails – challenging the status quo of artificial cycle frozen embryo transfers |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1472648323004522 https://dx.doi.org/10.1016/j.rbmo.2023.103352 https://www.ncbi.nlm.nih.gov/pubmed/37804605 https://www.proquest.com/docview/2874258804 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swEBelhbGXsbb7k3UrGoyxMbxElmLZj6GsZBvNy1bom5BkCVISO7Wdjuxh9Dv0G-6TTCfJgcHWwR5tdJbRnU931v1-h9ArqwCGI12aygqasDLLk9xQndiclUyTVBYGsMNns2x6zj5djC920EmPhYGyyuj7g0_33jreGcbVHK7m8-EXwjiUZ9GUBl5wQLAzDlb-_se2zIPkI0_FCYMTGB2BM6HGq1FLAACmFLDnHnz0583pb8Gn34ROH6IHMXrEk_CC-2jHVAfocFK5zHm5wa-xr-f0P8oP0L2zeGx-iC5nnr4Tv5GLZd12b7FcfJObFq8acy3nixb_vLnFOrZVcXsZdlEhBqjRusVX6xrXFsOaBLIJrDdubmyb-rupsFmqZlPjzse_LpR8hM5PP3w9mSaxyUKi2Zh0CTG2zMqcG65SoqUdlZLqkvJCpVSRkeWlHWV5qV32ql1wJnWqiGeFhwPXzBD6GO1WdWWeIsx55pK_PNU2L5iSTLqncUWdC0kVk4UcINKvrtCRgRwaYSxEX2p2KUAjAjQigkYG6N1WZhX4N-4cTXuliR5Z6nyhcNvDnVLjrdRvtvdPuZe9XQj3UcJJi6xMvW4FNBFIx841sgF6Egxm-_YUKJ9cEvnsP2c9QvfhKpTUPEe7XbM2L1xg1Kljb_nHaG_y8fN09gvN-AyB |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4anQS8INhglKuREAKhqHXs3B6rialja1_YpL1ZtuNIndqkJCmoPPEf-If8EnwcpxISDInXxCe2fDmX-HzfAXhdKIThSBum8owFPI_TIDVMB0XKc65pKDOD2OHZPJ5e8o9X0dUeHPdYGEyr9Lq_0-lOW_snIz-bo_ViMfpEeYLpWSxkHS_4LdhHdqpoAPuT07PpfHeZkI4dGye2D1DAY2e6NK9arRADGDKEnzv80Z_t09_8T2eHTu7DPe9Akkk3xgewZ8oDOJyUNnhebckb4lI63b_yA7g98zfnh3A9dwye5K1crqqmfUfk8qvcNmRdmy9ysWzIz-8_iPaVVaw5I9YxJIg22jTk86YiVUFwWjq-CaK3tm9S1NU3UxKzUvW2Iq1zga03-RAuTz5cHE8DX2ch0DyibUBNkcd5mphEhVTLYpxLpnOWZCpkio6LJC_GcZprG8Bq659JHSrqiOHxzjU2lD2CQVmV5jGQJIlt_JeGukgzriSX9muJYlaLhIrLTA6B9rMrtCchx1oYS9Fnm10LXBGBKyK6FRnC-53MuqPguLE16xdN9OBSqw6FtRA3SkU7qd-23z_lXvX7QthziZctsjTVphFYRyCMrHbkQzjqNsxu9AxZn2wc-eQ_e30Jd6YXs3Nxfjo_ewp38U2XYfMMBm29Mc-tn9SqF_4c_AL3tQ8y |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nature+%28almost%29+always+prevails+%E2%80%93+challenging+the+status+quo+of+artificial+cycle+frozen+embryo+transfers&rft.jtitle=Reproductive+biomedicine+online&rft.au=Santos-Ribeiro%2C+Samuel&rft.au=Godinho%2C+Catarina+M&rft.au=Reis-Soares%2C+S%C3%A9rgio&rft.date=2023-12-01&rft.issn=1472-6483&rft.volume=47&rft.issue=6&rft.spage=103352&rft_id=info:doi/10.1016%2Fj.rbmo.2023.103352&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_rbmo_2023_103352 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6483&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6483&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6483&client=summon |